Trials / Completed
CompletedNCT03148678
Scrutinizing and Promoting Mindfulness Via New Technologies
Scrutinizing and Promoting Mindfulness Via New Technologies: Smartphone-based Assessment and Micro-intervention and Functional Magnetic Resonance Imaging (fMRI) (-Neurofeedback)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The overall goal of the outlined study is to scrutinize and to promote mindfulness via new technologies using a combination of smartphone-based assessment and micro-interventions, fMRI and real-time fMRI-neurofeedback.
Detailed description
The overall goal of the outlined study is to scrutinize and to promote mindfulness via new technologies using a combination of smartphone-based assessment and micro-interventions, fMRI and real-time fMRI-neurofeedback. More specifically, we aim to i) evaluate whether smartphone-based micro-interventions affect mindfulness, stress, and mood, ii) evaluate whether mindfulness, its neural substrate, and related mental and physiological functions can be modified by training volitional control over brain activity by means of real-time functional magnetic resonance imaging neurofeedback (RT-fMRI-NF), iii) differentiate neural activation patterns during mindfulness vs. mind wandering.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Mindfulness | Subjects are provided with smartphone-based mindfulness intervention. |
| OTHER | Contingent RT-fMRI-NF | Subjects are provided with contingent RT-fMRI-NF of their own brain activity. |
| OTHER | Sham RT-fMRI-NF | Subjects are provided with sham RT-fMRI-NF of brain activity of previously recorded subject. |
| BEHAVIORAL | Mind Wandering | Subjects are provided with smartphone-based mind wandering intervention. |
Timeline
- Start date
- 2017-03-31
- Primary completion
- 2019-03-05
- Completion
- 2019-03-05
- First posted
- 2017-05-11
- Last updated
- 2024-12-16
Locations
2 sites across 2 countries: South Korea, Switzerland
Source: ClinicalTrials.gov record NCT03148678. Inclusion in this directory is not an endorsement.